Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial.
Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Neilsson M, Jacobson JG J Am Acad Child & Adolesc Psychiatry, 2002 41(10) 1205-1215
Mood disorders in children and adolescents: Psychopharmacological treatment
Emslie GJ, Mayes TL. Biol Psychiatry 2001 49 1082-1090
Fluoxetine in child and adolescent depression: Acute and maintenance treatment
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL Depression and Anxiety 1998 7 32-39
A double-blind, randomized, placebo-controlled study of fluoxetine in depressed children and adolescents
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes, CW, Carmody T, Rintelmann JW Arch Gen Psychiatry 1997 54 1031-1037
A feasibility study of the Childhood MDD Medication Algorithm: The Texas Children`s Medication Algorithm Project (CMAP).
Emslie, GJ, Hughes CW, Crismon ML, Lopez, M, Pliszka S, Toprac, M, Boemer C. Journal of the American Academy Child and Adolescent Psychiatry 2004 43(5) 519-27
Predictors of response to treatment in children and adolescents with mood disorders.
Emslie GJ, Mayes TL, Laptook RS, Batt M. The Psychiatric clinics of North America. Depression: Recent Developments and Innovative Treatments. Rosenbaum JF, Dunner DL (eds.). W.B. Saunders Company, Philadelphia, PA 2003 435-456
Treatment for Adolescents with Depression Study (TADS): Rationale, design, and methods
Treatment for Adolescents with Depression Study Team Journal of the American Academy of Child & Adolescent Psychiatry 2003 42 531-542